Aldo-Keto Reductase Family 1 Member C3
"Aldo-Keto Reductase Family 1 Member C3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Aldo-keto reductase that functions as a bi-directional 17 BETA, 20 ALPHA-HYDROXYSTEROID DEHYDROGENASE. It catalyzes the reduction of PROSTAGLANDIN D2 and PROSTAGLANDIN H2, as well as the oxidation of 9alpha,11beta-PGF2 to prostaglandin D2. It can also interconvert estrogens, ANDROGENS; and PROGESTINS between their active forms and inactive metabolites.
| Descriptor ID |
D000074425
|
| MeSH Number(s) |
D08.811.682.047.150.700.156.875 D08.811.682.047.436.375.140 D08.811.682.047.820.284.937 D08.811.682.047.820.375.500
|
| Concept/Terms |
Aldo-Keto Reductase Family 1 Member C3- Aldo-Keto Reductase Family 1 Member C3
- Aldo Keto Reductase Family 1 Member C3
- 17-beta-Hydroxysteroid Dehydrogenase Type 5
- 17 beta Hydroxysteroid Dehydrogenase Type 5
- AKR1C3 Protein
- Dihydrodiol Dehydrogenase 3
|
Below are MeSH descriptors whose meaning is more general than "Aldo-Keto Reductase Family 1 Member C3".
Below are MeSH descriptors whose meaning is more specific than "Aldo-Keto Reductase Family 1 Member C3".
This graph shows the total number of publications written about "Aldo-Keto Reductase Family 1 Member C3" by people in this website by year, and whether "Aldo-Keto Reductase Family 1 Member C3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aldo-Keto Reductase Family 1 Member C3" by people in Profiles.
-
Identification of novel epithelial ovarian cancer loci in women of African ancestry. Int J Cancer. 2020 06 01; 146(11):2987-2998.
-
A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells. Biochem Pharmacol. 2014 Mar 01; 88(1):36-45.
-
Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors. Cancer Res. 2012 Dec 01; 72(23):6142-52.